Japan· JP-4300453A1028
フロルベタピル（１８Ｆ）
A florbetapir (18f) product containing フロルベタピル（１８ｆ）, registered in Japan by ＰＤＲファーマ, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Florbetapir (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX05 (florbetapir (18f)), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Florbetapir (18f) · ATC V09AX05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フロルベタピル（１８Ｆ）
- Manufacturer
- ＰＤＲファーマ
- Country
- Japan (JP)
- ATC code
- V09AX05
- ATC class
- Florbetapir (18F)
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Florbetapir (18f) in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMYVIDEli Lilly Nederland B.V., Utrecht
- SpainAMYVID 1.900 MBq/ml solucion inyectableEli Lilly Nederland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- IrelandAmyvid 1,900 MBq/mL solution for injectionEli Lilly Nederland B.V.
- SwedenAmyvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- United StatesAmyvidEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amyvid
- Liechtenstein · Amyvid
- Norway · Amyvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad1a3216-e4e4-4237-a768-07d1402ec607 GET /v1/drugs/ad1a3216-e4e4-4237-a768-07d1402ec607?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３７０ＭＢｑ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4300453A1028",
"category": "注射薬",
"price_yen": 184203,
"generic_name": "フロルベタピル（１８Ｆ）",
"product_name_jp": null,
"therapeutic_class": "4300",
"transitional_expiry": null
}See everything about florbetapir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.